High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations

European Journal of Human Genetics

Volumn 21, Issue 4, 2013, Pages 469-470

  Heesterman, Berdine L ^a   Bayley, Jean Pierre ^a   Tops, Carli M ^a   Hes, Frederik J ^a   Van Brussel, Bernadette T J ^a   Corssmit, Eleonora P M ^a   Hamming, Jaap F ^a   Van Der Mey, Andel G L ^a   Jansen, Jeroen C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

carotid body tumor; genetic testing; paraganglioma; SDHB; SDHD

Indexed keywords

SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE B; SUCCINATE DEHYDROGENASE D; UNCLASSIFIED DRUG;

ARTICLE; ASYMPTOMATIC DISEASE; CAROTID BODY TUMOR; DISEASE CARRIER; GENE MUTATION; GENETIC SCREENING; HEAD AND NECK TUMOR; HETEROZYGOTE; HUMAN; HYPOGLOSSAL NERVE PALSY; LARYNGEAL NERVE; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PARASYMPATHETIC GANGLION; PHEOCHROMOCYTOMA; PREVALENCE; PRIORITY JOURNAL; SYMPATHETIC GANGLION; TUMOR GROWTH;

ASYMPTOMATIC DISEASES; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HEAD AND NECK NEOPLASMS; HETEROZYGOTE; HUMANS; MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; SUCCINATE DEHYDROGENASE;

EID: 84875050655     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.203     Document Type: Article

References (11)

1. Astuti D, Latif F, Dallol A et al: Gene mutations in the succinate dehydrogenase subunitSDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.Am J Hum Genet 2001; 69: 49-54. (Pubitemid 32614017)
2. Baysal BE, Ferrell RE, Willett-Brozick JE et al: Mutations in SDHD, a mitochondrialcomplex II gene, in hereditary paraganglioma. Science 2000; 287: 848-851. (Pubitemid 30084326)
3. Hao HX, Khalimonchuk O, Schraders M et al: SDH5, a gene required for flavinationof succinate dehydrogenase, is mutated in paraganglioma. Science 2009; 325:1139-1142.
4. Niemann S, Muller U: Mutations in SDHC cause autosomal dominant paraganglioma,type 3. Nat Genet 2000; 26: 268-270.
5. Opocher G, Schiavi F: Genetics of pheochromocytomas and paragangliomas. BestPract Res Clin Endocrinol Metab 2010; 24: 943-956.
6. Hensen EF, Jansen JC, Siemers MD et al: The Dutch founder mutation SDHD.D92Yshows a reduced penetrance for the development of paragangliomas in a largemultigenerational family. Eur J Hum Genet 2010; 18: 62-66.
7. Kunst HP, Rutten MH, de Monnink JP et al: SDHAF2 (PGL2-SDH5) and hereditaryhead and neck paraganglioma. Clin Cancer Res 2011; 17: 247-254.
8. Neumann HP, Pawlu C, Peczkowska M et al: Distinct clinical features of paragangliomasyndromes associated with SDHB and SDHD gene mutations. JAMA 2004; 292:943-951. (Pubitemid 39097204)
9. Havekes B, van der Klaauw AA, Weiss MM et al: Pheochromocytomas and extra-adrenalparagangliomas detected by screening in patients with SDHD-associated head-andneckparagangliomas. Endocr Relat Cancer 2009; 16: 527-536.
10. Hes FJ, Weiss MM, Woortman SA et al: Low penetrance of a SDHB mutation in a largeDutch paraganglioma family. BMC Med Genet 2010; 11: 92.
11. NIH state-of-the-science statement on management of the clinically inapparentadrenal mass ("incidentaloma"). NIH Consens State Sci Statements 2002; 19: 1-25.